To have a focused view of the most significant associations, we examined drugs that were significantly associated with the expression of at least one IAP in at least 8 cancer types (32% of the cancers) which led to 10 drugs targeting 5 major pathways including EGFR signaling, ERK MAPK signaling, genome integrity, PI3K/MTOR signaling, and WNT signaling (Fig. 8). Here, MTOR is linked to cancer.